Fair balance & risk presentation
Every risk claim is checked for prominence, readability, and consistency with the PI. The fair-balance report flags any imbalance between efficacy and risk presentation.
The Enforcement-Risk Clearance Engine assembles a submission-ready, pre-cleared package — every claim substantiated, every fair-balance element checked, every risk flag mapped to live OPDP enforcement letters — reviewed by a licensed regulatory specialist before release.
Every promotional asset must clear MLR before use, and MLR is the acknowledged bottleneck — 50-60 days per piece in the US vs ~20 in the EU, with siloed feedback and manual rework. In 2025 the cost of getting it wrong spiked: FDA sent 200+ enforcement letters, many hitting DTC risk presentation.
Small/mid brands and agencies feel this hardest: they lack a full PRC, can't absorb six-figure enterprise platforms, and face launch dates that slip every time review stalls. The pain is simultaneously speed (missed launch windows), cost (expensive reviewers/agencies), and risk (public enforcement).
The Enforcement-Risk Clearance Engine exists to close that gap with a single, exhaustive standard applied identically to every file.
We do not summarize the law and hope. Every pack is scored against a versioned rule pack tied to the exact text of 21 CFR 202.1, Part 801, and FDCA 502(n). These are the provisions each pack is held to.
Every risk claim is checked for prominence, readability, and consistency with the PI. The fair-balance report flags any imbalance between efficacy and risk presentation.
Every efficacy or safety claim is linked to a specific reference (label, clinical study, or published literature). Unsubstantiated claims are flagged with the supporting evidence gap.
For DTC print ads, the brief summary is verified for completeness. For broadcast, the adequate provision (major statement) is checked against the PI.
All promotional claims are cross-referenced against the approved PI/label. Any deviation in indication, dosing, or safety language is flagged.
Each claim is compared against the live corpus of OPDP Untitled and Warning Letters (200+ from 2025). Similar language or presentation patterns are flagged with the relevant letter citation.
The package includes a completed Form 2253 draft, with all required fields populated and the asset attached, ready for submission within 5 business days of approval.
AI extracts and drafts. Deterministic rules — running as code, outside the model — decide what is complete. A human specialist signs every release. That order is never reversed.
Upload the asset and PI. We return a free completeness read: which regulatory elements and substantiation you already have, and which are missing.
As your authorized clerical agent, we ingest the PI, clinical references, and any prior OPDP letters. We build a claim-reference matrix corroborated across sources.
The claim-substantiation matrix, fair-balance report, and risk flags are drafted from your validated data and the regulatory rule pack into field-locked templates — no legal opinions, no invented facts.
Every claim is linked to a reference; fair-balance metrics are computed; the OPDP corpus is searched for similar language; Form 2253 fields are populated. Any failure blocks release.
A licensed regulatory reviewer verifies the off-label/medical/risk chokepoints and signs the release. High-risk or novel claims route to attorney review first.
You receive the pack: annotated asset, claim-substantiation matrix, fair-balance report, risk-flag report with OPDP citations, suggested redlines, and a Form 2253-ready dossier — ready for internal MLR submission.
The deliverable is a pre-cleared package — every regulatory element and substantiation accounted for or explicitly exception-coded. Nothing is left implicit.
The gates that decide completeness are code, not a model's opinion. A drafting error cannot slip past a regulatory requirement.
We prepare documentation and run searches as your clerical agent. We never provide legal advice, approve the asset, or submit to FDA on your behalf.
Simple, predictable, and aligned with a documentation standard — not a cut of any revenue.
Start with a free Risk Gap Scan. Send your asset and PI and we'll return a completeness read against every subsection of 21 CFR 202.1 and the OPDP enforcement corpus.
Documentation-completeness service · not legal advice · your team retains full approval authority.